Skip to main navigation Skip to search Skip to main content

Potential cancer screening biomarker - anti-tNASP antibodies exploration in prostate, pancreatic, and ovarian cancers

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Dec 1 2022

Disciplines

  • Oncology

Cite this